Releases New Report on the Metagenomics Sequencing Market 2020-2025 | Top Key Players - Thermo Fisher, Agilent, Enterome, Illumina, Oxford Nanopore Technologies, PerkinElmer, Qiagen

Global Metagenomics Sequencing Market Synopsis:

The exclusive research report on the Global Metagenomics Sequencing Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Metagenomics Sequencing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Most important key factors driving the growth of the Global Metagenomics Sequencing Market are rapid growth in the awareness of genetic disorders, advanced technological platforms and improved genomic tools, significant applications of metagenomics in various fields, the various initiatives and funding from government & private bodies for large-scale sequencing projects, and the declining cost of sequencing.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273411 .

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion. The Metagenomics Sequencing Market is segmented based on Product, source, application and Regions. On the basis of product, the market is sub-segmented.

In terms of the regional analysis, North America commanded the largest share of the Metagenomics Sequencing Market in 2018. This can primarily be attributed to favorable initiatives by government and private bodies for the development and adoption of NGS-based metagenomics technologies, the wide adoption of metagenomic diagnostics in the region, increasing number of NGS-based metagenomic research & clinical applications in the region, and rising awareness of metagenomics sequencing services.

Top Major Key Players in the Global Metagenomics Sequencing Market:

1 Agilent Technologies

2 Enterome SA

3 F. Hoffmann

4 Illumina

5 Oxford Nanopore Technologies

6 Pacific Biosciences of California

7 PerkinElmer

8 Qiagen

9 Swift Biosciences

10 Thermo Fisher Scientific and More…………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Metagenomics Sequencing Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273411/single .

Product Type Segmentation

1 Instrument and Software

2 Consumables

Industry Segmentation

1 Infectious Disease Diagnosis

2 Environmental Remediation

3 Gut Microbe Characterization

4 Biotechnology

5 Biofuel

Latest Business News:

Thermo Fisher Scientific (July 16, 2020) - Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Thermo Fisher Scientific Inc., the world leader in serving science, and QIAGEN N.V., a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN.

The amendment provides for an increase from the original offer price of €39.00 to a new price of €43.00 per QIAGEN share in cash, which represents a premium of approximately 35% to the closing price of QIAGEN's ordinary shares on the Frankfurt Prime Standard on March 2, 2020, the last trading day prior to the announcement of the acquisition agreement and Thermo Fisher's intention to commence the offer. The amendment also provides for a reduction of the minimum acceptance threshold from 75% to 66.67% of QIAGEN's issued and outstanding ordinary share capital at the end of the acceptance period on August 10, 2020, as well as a USD 95 million expense reimbursement to Thermo Fisher if the minimum acceptance threshold is not met.

The members of QIAGEN's Supervisory Board and Managing Board have reaffirmed their unanimous support for the offer and their unanimous recommendation that all QIAGEN shareholders accept and tender all of their QIAGEN shares in the offer prior to the end of the acceptance period, which has now been extended to August 10, 2020. Each of the members of the Supervisory Board and Managing Board has tendered or will tender all of their QIAGEN shares in the offer.

Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific, said, "Industry dynamics have changed considerably in the past few months, creating tailwinds and headwinds for our businesses. Both of our companies are playing important roles in helping customers to battle the COVID-19 pandemic. After careful consideration, we've decided to increase our offer for QIAGEN to reflect the fair value of the business given the current environment. We remain confident that this transaction will create shareholder value and, importantly, provide meaningful benefits to our customers and society by combining our capabilities to combat infectious diseases and other healthcare issues. We continue to look forward to completing the transaction in the first half of 2021."

"After carefully considering the updated offer by Thermo Fisher, QIAGEN's Supervisory Board and Managing Board both unanimously recommend that shareholders accept this offer given that it reflects the improvements in our business performance and future prospects as a result of the coronavirus pandemic," said Thierry Bernard, chief executive officer of QIAGEN N.V. "The rationale for this strategic step is stronger than ever, especially as the value of molecular testing becomes ever more evident. This combination is designed to enable QIAGEN employees and our portfolio of Sample to Insight solutions to have an even greater impact on society while also delivering significant cash value to our shareholders. We look forward to working closely with Thermo Fisher to successfully complete the transaction."

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273411 .

Major Points in Table of Contents:

Global Metagenomics Sequencing Market Report 2020

1 Metagenomics Sequencing Product Definition

2 Global Metagenomics Sequencing Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Metagenomics Sequencing Shipments

2.2 Global Manufacturer Metagenomics Sequencing Business Revenue

2.3 Global Metagenomics Sequencing Market Overview

2.4 COVID-19 Impact on Metagenomics Sequencing Industry

3 Manufacturer Metagenomics Sequencing Business Introduction

3.1 Agilent Technologies Metagenomics Sequencing Business Introduction

3.2 Enterome SA Metagenomics Sequencing Business Introduction

3.3 F. Hoffmann Metagenomics Sequencing Business Introduction

3.4 Illumina Metagenomics Sequencing Business Introduction

3.5 Oxford Nanopore Technologies Metagenomics Sequencing Business Introduction

3.6 Pacific Biosciences of California Metagenomics Sequencing Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.